International Biotechnology Trust PLC Fate Therapeutics Inc Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$9.86 - $23.83 $739,500 - $1.79 Million	-75,000 Reduced 61.98%	46,000 $464,000
Q3 2022 Nov 08, 2022	BUY	$21.04 - $36.06 $2.46 Million - $4.22 Million	117,083 Added 2989.1%	121,000 $2.71 Million
Q2 2022 Aug 16, 2022	SELL	$17.78 - $42.39 $428,195 - $1.02 Million	-24,083 Reduced 86.01%	3,917 $158 Million
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $1.66 Million - $2.68 Million	28,000 New	28,000 $1.66 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.